MD, Amygdala Ltd.
Dr Juliana Bottomley’s expertise embraces commercial clinical development and health outcomes in ‘blue chip’ pharmaceutical companies and in consultancy. She is the Managing Director of Amygdala, with more than 20 years’ experience in the health outcomes and market access field. Juliana and HJCL have worked together on several health technology appraisal projects, including product submissions to the National Institute for Health and Care Excellence and the Scottish Medicines Consortium. You can find out more here: Amygdala Ltd